Abstract
This study aimed at contributing to the evidence base of economic burden caused due to type-II DM. The data were obtained from the 158 diabetics from the three tertiary hospitals in Shillong, Meghalaya, during January–March 2017 with the use of a semi-structured questionnaire. The information received was cross-checked with the medical records from the finance department. Patients comprised of 86 (54.4%) females and 72 (45.6%) males. The individuals under the age group of 56–65 were 49 (31%). The total median cost of illness per month was Rs. 5375 (2524–18,968) which was made up of 70.92% direct cost and 29.08% indirect cost. 58.2% respondents used their savings for getting treatment. The cost of care is high and comparable to cost in other countries. An improved understanding of COI of type-II DM will help in informing and motivating the policy and health decision makers which will reduce the national burden of this disease.
| Original language | English |
|---|---|
| Pages (from-to) | 201-205 |
| Number of pages | 5 |
| Journal | International Journal of Diabetes in Developing Countries |
| Volume | 39 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 01-01-2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
Fingerprint
Dive into the research topics of 'Cost of illness (COI) of type-II diabetes mellitus in Shillong, Meghalaya'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver